You are here

JNJ

J&J discontinues late-stage study for bladder cancer drug

Reuters

Mon, 10/7/24 - 10:01 pm

clinical trials

J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study

Fierce Pharma

Wed, 10/2/24 - 09:50 pm

prostate cancer

High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project

Fierce Pharma

Wed, 10/2/24 - 11:27 am

medicine foundry

drug manufacturing

Big Pharma's layoff wave in New Jersey rolls on with hundreds of J&J cuts, 57 at Bayer

Fierce Pharma

Tue, 10/1/24 - 10:19 pm

As urged by the AHA and others, J&J tells HRSA it is abandoning proposed 340B rebate plan

American Hospital Association

Mon, 09/30/24 - 09:00 pm

After Sanofi's first-line myeloma nod, J&J strikes back with new tranche of Darzalex data

Fierce Pharma

Mon, 09/30/24 - 09:30 am

Darzalex Faspro

Multiple Myeloma

J&J to shutter cardiovascular, metabolic drug unit

Seeking Alpha

Thu, 09/26/24 - 03:15 pm

cardiovascular disease

metabolic diseases

Johnson & Johnson Files for Bankruptcy Over Talc Lawsuits for the Third Time

Yahoo/Zacks.com

Mon, 09/23/24 - 10:25 pm

J&J hopes 3rd time's the charm for Texas two-step strategy as it lifts talc settlement offer to $8B

Fierce Pharma

Mon, 09/23/24 - 09:51 am

At J&J, oncology R&D meets commercial strategy in a quest for new standards of care

Pharma Voice

Thu, 09/19/24 - 09:22 am

Agency warns J&J over 340B rebate plan

Beckers Hospital Review

Wed, 09/18/24 - 12:26 pm

ESMO: J&J cues up phase 3 for Rybrevant in colorectal cancer

Pharmaphorum

Mon, 09/16/24 - 09:45 am

colorectal cancer

J&J leads $50M financing for imaging company Spectrawave

Medtech Dive

Thu, 09/12/24 - 10:20 am

Medical Imaging

venture capital

FDA expands J&J's psoriasis drug for inflammatory bowel disease

Reuters

Wed, 09/11/24 - 10:59 pm

ulcerative colitis

J&J Unveils New Branding for Medical Device Units

Medical Devices and Diagnostics Industry

Wed, 09/11/24 - 10:56 pm

Johnson & Johnson MedTech

Biosense Webster

J&J bolsters Rybrevant-Lazcluze's case against AZ's Tagrisso with survival analysis

Fierce Pharma

Sun, 09/8/24 - 11:38 pm

non-small cell lung cancer

Evernorth Will Offer a Private-Label Stelara Biosimilar in 2025

Managed Healthcare Executive

Thu, 09/5/24 - 10:32 pm

Evernorth Health

Court tells J&J to pay $1 billion more for 2019 robotics deal

Axios Health

Thu, 09/5/24 - 11:06 am

robotic surgery

Johnson & Johnson adds $1.1 billion to proposed talc settlement

Reuters

Wed, 09/4/24 - 10:47 pm

J&J submits touted autoimmune disease drug for FDA approval

BioPharma Dive

Thu, 08/29/24 - 11:24 am

myasthenia gravis

Pages